Search Results

You are looking at 1 - 10 of 1,580 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Epidemiology, Natural History, and Practice Patterns of Patients with Myelodysplastic Syndromes in 2010

Mikkael A. Sekeres

occurred in 11% of recently diagnosed patients. Table 2 Survey-Based Characteristics of Patients With MDS Lower-risk MDS was more common than higher-risk MDS among both recently diagnosed cases (68%–69% vs. 31%–32%, respectively) and

Full access

Characteristics Associated With Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults

Kah Poh Loh, Vivian Lam, Katey Webber, Simran Padam, Mina S. Sedrak, Vivek Musinipally, Madison Grogan, Carolyn J. Presley, Janice Grandi, Chandrika Sanapala, Daniel A. Castillo, Grace DiGiovanni, Supriya G. Mohile, Louise C. Walter, and Melisa L. Wong

characteristics are associated with these changes can inform shared decision-making to individualize cancer care. Identifying which patients are at highest risk of functional decline is necessary to weigh the potential benefits and harms of treatment options, to

Full access

Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer

Jake S. Jacob, Barbara E. Dutra, Victor Garcia-Rodriguez, Kavea Panneerselvam, Fiyinfoluwa O. Abraham, Fangwen Zou, Weijie Ma, Petros Grivas, John A. Thompson, Mehmet Altan, Isabella C. Glitza Oliva, Hao Chi Zhang, Anusha S. Thomas, and Yinghong Wang

and the ICI therapy course and lead to morbidity and mortality. Given the limited data on IMM, we evaluated the clinical characteristics, disease course, treatment, and outcome of IMM in patients at a tertiary cancer center. Methods Study

Full access

Edmonton Symptom Assessment Scale and Clinical Characteristics Associated With Cannabinoid Use in Oncology Supportive Care Outpatients

Young D. Chang, Jae-Woo Jung, Ritika Oberoi-Jassal, Jongphil Kim, Sahana Rajasekhara, Meghan Haas, Joshua Smith, Vijay Desai, Kristine A. Donovan, and Diane Portman

characteristics among patients with positive versus negative test results. Patients and Methods Study Population A retrospective medical records review was performed to identify reported differences in symptom characteristics of cannabinoid users and nonusers

Full access

End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical Trials

Ramy Sedhom, Amanda L. Blackford, Arjun Gupta, Kelly Griffiths, Janet Heussner, and Michael A. Carducci

solid cancer and enrollment in a phase I intervention trial. The primary objective of this study was to identify patient and treatment characteristics associated with a short hospice LOS (≤3 days). Data Collection Patient demographics and EOL

Full access

Lung Cancer in Nonelderly Patients: Facility and Patient Characteristics Associated With Not Receiving Treatment

Elizabeth A. Nardi, Can-Lan Sun, Francisco Robert, and Julie A. Wolfson

(“treatment”). Sociodemographic Characteristics The following sociodemographic variables were included in multivariable analyses: (1) age (continuous variable); (2) year of diagnosis (11 categories); (3) race/ethnicity (non-Hispanic white [NHW], black

Full access

EPR19-072: Breast Cancer Laterality and Immunohistochemical Characteristics

Tarek Safi, Pascale Salameh, Lea Aoude, Mirna Waked, FCCP, and Bassim Kobrossy

looking at differences in immunohistochemical characteristics between left and right sided breast cancer. This study aims to assess the incidence and age distribution as well as the following immunohistochemical characteristics: estrogen receptor (ER

Full access

A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States

Christopher Nevala-Plagemann, Shashank Sama, Jian Ying, Jincheng Shen, Benjamin Haaland, Vaia Florou, and Ignacio Garrido-Laguna

review of the EHR, Social Security Death Index, and review of obituaries. 19 Statistical Analysis Baseline characteristics of patients who received TAS-102 alone or prior to receiving regorafenib (TAS-102 group) versus those who received

Full access

Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States

Benjamin H. Kann, Henry S. Park, Skyler B. Johnson, Veronica L. Chiang, and James B. Yu

-beam RT to the brain who met the inclusion criteria. Statistical Methodology Patient-level characteristics included age, year of diagnosis, sex, malignancy type, Charlson-Deyo comorbidity score (CDS), race/ethnicity, insurance status, distance from

Full access

Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy

Douglas W. Blayney, Nicole M. Kuderer, Alice Kate Cummings Joyner, John Jarvis, Dominic Nunag, Jasmine Wells, Lan Huang, Ramon Mohanlal, and Gary H. Lyman

our analysis. Rates of PP G-CSF use, defined as ≥1 claim for a G-CSF on or up to 3 days after the date of chemotherapy initiation (index date), were assessed overall and by regimen. Baseline characteristics were evaluated during the 6-month period